JWH-184
Overview[edit | edit source]
JWH-184 is a synthetic cannabinoid that acts as a potent agonist at the cannabinoid receptors. It is part of the naphthoylindole family of compounds, which are known for their ability to mimic the effects of tetrahydrocannabinol (THC), the primary psychoactive component of cannabis.
Chemical Properties[edit | edit source]
JWH-184 has the chemical formula C24H23NO and a molecular weight of 341.45 g/mol. It is characterized by its naphthoylindole structure, which consists of a naphthalene ring linked to an indole moiety. This structure is crucial for its activity at cannabinoid receptors.
Pharmacology[edit | edit source]
JWH-184 functions as a full agonist at both the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes such as pain, mood, and appetite. The activation of these receptors by JWH-184 can lead to effects similar to those produced by natural cannabinoids.
Legal Status[edit | edit source]
Due to its potential for abuse and lack of medical use, JWH-184, like many synthetic cannabinoids, is classified as a controlled substance in many jurisdictions. The legal status of JWH-184 can vary significantly between countries and regions.
Synthesis[edit | edit source]
The synthesis of JWH-184 involves the condensation of a naphthoyl chloride with an indole derivative. This reaction typically requires the use of a base to facilitate the formation of the naphthoylindole structure. The synthesis of JWH-184 is similar to that of other compounds in the JWH series, named after the chemist John W. Huffman, who first synthesized many of these compounds.
Potential Risks and Effects[edit | edit source]
The use of JWH-184, like other synthetic cannabinoids, can pose significant health risks. These compounds can produce unpredictable and sometimes severe effects, including tachycardia, hypertension, hallucinations, and psychosis. The lack of regulation and quality control in the production of synthetic cannabinoids further increases the risk of adverse effects.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
